Novartis Bioventures Ltd Insider Trading $GRTX Galera Therapeutics, Inc.
Get free email notifications about insider trading for Novartis Bioventures Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Novartis Bioventures Ltd. Novartis Bioventures Ltd is 10% Owner in Marina Biotech, Inc. ($MRNA) and 10% Owner in Altimmune, Inc. ($PIP) and 10% Owner in Tokai Pharmaceuticals Inc ($TKAI) and 10% Owner in AILERON THERAPEUTICS INC ($ALRN) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Akebia Therapeutics, Inc. ($AKBA) and in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in BICYCLE THERAPEUTICS plc ($BCYC).
Novartis Bioventures Ltd in Galera Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd:
Holdings: 3,469,273 shares
Latest Transaction: Jun 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Novartis Bioventures Ltd in Galera Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRX, AGLE, ARPO, ALRN, AKBA, ALT, BCYC, ELDN, GRTX, RARX, YMTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | Sell | S | 8.25 | 1,001,312 | 8,260,824 | 2,467,961 | 3.5 M to 2.5 M (-28.86 %) | |
| Jun 22 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | Sell | S | 9.04 | 900 | 8,136 | 3,469,273 | 3.5 M to 3.5 M (-0.03 %) | |
| Jun 22 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | Sell | S | 8.25 | 1,001,312 | 8,260,824 | 2,467,961 | 3.5 M to 2.5 M (-28.86 %) | |
| Jun 22 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | Sell | S | 9.04 | 900 | 8,136 | 3,469,273 | 3.5 M to 3.5 M (-0.03 %) | |
| Jun 17 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.27 | 4,622 | 42,846 | 3,470,173 | 3.5 M to 3.5 M (-0.13 %) |
| Jun 17 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.30 | 8,600 | 79,980 | 3,474,795 | 3.5 M to 3.5 M (-0.25 %) |
| Jun 17 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.05 | 6,164 | 55,784 | 3,483,395 | 3.5 M to 3.5 M (-0.18 %) |
| Jun 12 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.19 | 1,500 | 13,785 | 3,489,559 | 3.5 M to 3.5 M (-0.04 %) |
| Jun 12 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.21 | 7,200 | 66,312 | 3,491,059 | 3.5 M to 3.5 M (-0.21 %) |
| Jun 12 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.46 | 8,532 | 80,713 | 3,498,259 | 3.5 M to 3.5 M (-0.24 %) |
| Jun 09 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.38 | 7,000 | 65,660 | 3,506,791 | 3.5 M to 3.5 M (-0.20 %) |
| Jun 09 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.66 | 5,659 | 54,666 | 3,513,791 | 3.5 M to 3.5 M (-0.16 %) |
| Jun 09 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.66 | 8,652 | 83,578 | 3,519,450 | 3.5 M to 3.5 M (-0.25 %) |
| Jun 04 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.55 | 4,088 | 39,040 | 3,528,102 | 3.5 M to 3.5 M (-0.12 %) |
| Jun 04 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.78 | 5,208 | 50,934 | 3,532,190 | 3.5 M to 3.5 M (-0.15 %) |
| Jun 04 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.68 | 5,669 | 54,876 | 3,537,398 | 3.5 M to 3.5 M (-0.16 %) |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 451,609 | 0 | 0 | |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 7,200,000 | 0 | 0 | |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 9,000,000 | 0 | 0 | |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Buy | P | 12.00 | 250,000 | 3,000,000 | 3,543,067 | 3.3 M to 3.5 M (+7.59 %) |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Buy | C | 0.00 | 3,293,067 | 0 | 3,293,067 | 0 to 3.3 M |
Page: 1